Opens profile photo
Follow
TrialSpark
@TrialSpark
Bringing new medical treatments to patients faster by reimagining the clinical trial process.
New York, NYtrialspark.comJoined November 2014

TrialSpark’s Tweets

Dr. Michael Mina of the Harvard T.H. Chan School of Public Health enrolled 500 patients in a COVID-19 serological surveillance study in just ten days using TrialSpark’s Covalence trial platform. Learn more about our partnership: prnewswire.com/news-releases/
Image
9